✦ LIBER ✦

Activation of growth factor receptors in pancreatic cancer

✍ Scribed by Thilo Welsch; Jörg Kleeff; Markus W. Büchler; Helmut Friess

Book ID: 116215903
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 328 KB
Volume: 194
Category: Article
ISSN: 0002-9610
DOI: 10.1016/j.amjsurg.2007.05.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phorbol Ester Reduces Phosphorylation of

Phorbol Ester Reduces Phosphorylation of Epidermal Growth Factor Receptor in Pancreatic Cancer Cells by Activation of a Tyrosine Phosphatase

✍ Jenny J.L. Ho; Ellyn R. Farrelly; Young S. Kim 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 191 KB

Mechanisms of aberrant epidermal growth

Mechanisms of aberrant epidermal growth factor receptor signaling in the absence of EGFR gene activating mutations in pancreatic cancer patients

✍ Ching-Wei D. Tzeng; Andrey Frolov; Natalya Frolova; Nirag C. Jhala; Andra R. Fro 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Concurrent inhibition of NF-κB, cyclooxy

Concurrent inhibition of NF-κB, cyclooxygenase-2, and epidermal growth factor receptor leads to greater anti-tumor activity in pancreatic cancer

✍ Shadan Ali; Sanjeev Banerjee; Jacqueline M. Schaffert; Bassel F. El-Rayes; Phili 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 659 KB

## Abstract Inactivation of survival pathways such as NF‐κB, cyclooxygenase (COX‐2), or epidermal growth factor receptor (EGFR) signaling individually may not be sufficient for the treatment of advanced pancreatic cancer (PC) as suggested by recent clinical trials. 3,3′‐Diindolylmethane (B‐DIM) is

Amphiregulin regulates the activation of

Amphiregulin regulates the activation of ERK and Akt through epidermal growth factor receptor and HER3 signals involved in the progression of pancreatic cancer

✍ Fusanori Yotsumoto; Tatsuya Fukami; Hiroshi Yagi; Akihiro Funakoshi; Toshiyuki Y 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 769 KB

Cloning, sequencing, chromosomal wcation

Cloning, sequencing, chromosomal wcation, and function of a cdna encoding the opioid growth factor receptor (OGFR) in humans and a modulator of ogf activity in the growth of pancreatic and colorectal cancer

✍ Zagon, Ian S.; Verderame, Michael F.; Allen, Sandy S.; McLaughlin, Patricia J. 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 184 KB

Safety, Tolerability, Pharmacokinetics a

Safety, Tolerability, Pharmacokinetics and Antitumor Activity of Ganitumab, an Investigational Fully Human Monoclonal Antibody to Insulin-like Growth Factor Type 1 Receptor, Combined with Gemcitabine as First-line Therapy in Patients with Metastatic Pancreatic Cancer: A Phase 1b Study

✍ Okusaka, T.; Ikeda, M.; Fukutomi, A.; Kobayashi, Y.; Shibayama, K.; Takubo, T.; 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 157 KB